Dan Raghinaru

3.4k total citations
27 papers, 1.1k citations indexed

About

Dan Raghinaru is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Dan Raghinaru has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 12 papers in Genetics. Recurrent topics in Dan Raghinaru's work include Diabetes Management and Research (19 papers), Diabetes and associated disorders (12 papers) and Pancreatic function and diabetes (11 papers). Dan Raghinaru is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes and associated disorders (12 papers) and Pancreatic function and diabetes (11 papers). Dan Raghinaru collaborates with scholars based in United States, Canada and Saudi Arabia. Dan Raghinaru's co-authors include Roy W. Beck, H. Peter Chase, Richard M. Bergenstal, David M. Maahs, Robin L. Gal, Edward J. Holland, Mark J. Mannis, Mariya Dontchev, Nicole C. Foster and Stephanie N. DuBose and has published in prestigious journals such as Circulation, Diabetes Care and Diabetes.

In The Last Decade

Dan Raghinaru

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Dan Raghinaru

Since Specialization

Citations

This map shows the geographic impact of Dan Raghinaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Raghinaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Raghinaru more than expected).

Fields of papers citing papers by Dan Raghinaru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Raghinaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Raghinaru. The network helps show where Dan Raghinaru may publish in the future.

Co-authorship network of co-authors of Dan Raghinaru

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Raghinaru. A scholar is included among the top collaborators of Dan Raghinaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Raghinaru. Dan Raghinaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient-Reported Outcomes Improve with a Virtual Diabetes Care Model that Includes Continuous Glucose Monitoring 2024 ·Telemedicine Journal and e-Health ·Korey K. Hood, Richard M. Bergenstal, Terra Cushman, Robin L. Gal, Dan Raghinaru, Davida Kruger, Mary L. Johnson, Teresa McArthur, Amy D. Bradshaw, Beth A. Olson, Sean M. Oser, Tamara K. Oser, Craig Kollman, Ruth S. Weinstock, Roy W. Beck, Grazia Aleppo	1
2	Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes 2024 ·Clinical Diabetes ·Roy W. Beck, Carol J. Levy, Yogish C. Kudva, (unknown), Thomas Blevins, Dan Raghinaru, Jordan E. Pinsker	0
3	Older Adults Benefit From Virtual Support for Continuous Glucose Monitor Use But Require Longer Visits 2024 ·Journal of Diabetes Science and Technology ·Ruth S. Weinstock, Dan Raghinaru, Robin L. Gal, Richard M. Bergenstal, Amy D. Bradshaw, Terra Cushman, Craig Kollman, Davida Kruger, Mary L. Johnson, Teresa McArthur, Beth A. Olson, Sean M. Oser, Tamara K. Oser, Roy W. Beck, Korey K. Hood, Grazia Aleppo	2
4	A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70–180 mg/dL Versus Time-in-Tight-Range 70–140 mg/dL 2023 ·Diabetes Technology & Therapeutics ·Roy W. Beck, Dan Raghinaru, Peter Calhoun, Richard M. Bergenstal	39
5	Comprehensive Telehealth Model to Support Diabetes Self-Management 2023 ·JAMA Network Open ·Grazia Aleppo, Robin L. Gal, Dan Raghinaru, Davida Kruger, Roy W. Beck, Richard M. Bergenstal, Terra Cushman, Korey K. Hood, Mary L. Johnson, Teresa McArthur, Amy D. Bradshaw, Beth A. Olson, Sean M. Oser, Tamara K. Oser, Craig Kollman, Ruth S. Weinstock	12
6	149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes 2023 ·Diabetes ·Robin L. Gal, Dan Raghinaru, Grazia Aleppo, Beth A. Olson, Davida Kruger, Richard M. Bergenstal, Ruth S. Weinstock, (unknown), Teresa McArthur, (unknown), (unknown), Korey K. Hood, (unknown), (unknown), Craig Kollman, Roy W. Beck	1
7	The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring 2022 ·Diabetes Technology & Therapeutics ·Roy W. Beck, Dan Raghinaru, Peter Calhoun, Richard M. Bergenstal	2
8	Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial 2022 ·Diabetes Technology & Therapeutics ·Laya Ekhlaspour, Marissa Town, Dan Raghinaru, John W. Lum, Sue A. Brown, Bruce A. Buckingham	28
9	The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial 2022 ·Diabetes Technology & Therapeutics ·Dan Raghinaru, Peter Calhoun, Richard M. Bergenstal, Roy W. Beck	10
10	Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial 2022 ·Journal of Diabetes Science and Technology ·Laya Ekhlaspour, Dan Raghinaru, Gregory P. Forlenza, Elvira Isganaitis, Yogish C. Kudva, David W. Lam, Camilla Levister, Grenye O’Malley, Mei Mei Church, John W. Lum, Bruce A. Buckingham, Sue A. Brown	3
11	101-LB: Eighteen-Month Use of Closed-Loop Control (CLC): A Randomized, Controlled Trial 2020 ·Diabetes ·Sue A. Brown, Dan Raghinaru, Bruce A. Buckingham, Yogish C. Kudva, Lori M. Laffel, Carol J. Levy, Jordan E. Pinsker, R. Paul Wadwa, John W. Lum, Craig Kollman, Roy W. Beck, Boris Kovatchev	1
12	First Look at Control-IQ: A New-Generation Automated Insulin Delivery System 2018 ·Diabetes Care ·Sue A. Brown, Dan Raghinaru, Emma Emory, Boris Kovatchev	56
13	Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes 2017 ·Diabetes Care ·Tamara Spaic, Marsha Driscoll, Dan Raghinaru, Bruce A. Buckingham, Darrell M. Wilson, Paula Clinton, H. Peter Chase, David M. Maahs, Gregory P. Forlenza, Emily Jost, Irene Hramiak, Terri Paul, B. Wayne Bequette, Faye Cameron, Roy W. Beck, Craig Kollman, John W. Lum, Trang T. Ly, (unknown)	17
14	Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis 2015 ·Diabetes Care ·Bruce A. Buckingham, Dan Raghinaru, Fraser Cameron, B. Wayne Bequette, H. Peter Chase, David M. Maahs, Robert H. Slover, R. Paul Wadwa, Darrell M. Wilson, Trang T. Ly, Tandy Aye, Irene Hramiak, Cheril Clarson, Robert Stein, Patricia Gallego, John W. Lum, Judy Sibayan, Craig Kollman, Roy W. Beck, (unknown)	92
15	A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion 2014 ·Clinical ophthalmology ·Michael Stewart, Raj K. Maturi, Vincent Chen, Dan Raghinaru, (unknown)	22
16	Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry 2014 ·Diabetes Care ·Jenise C. Wong, Nicole C. Foster, David M. Maahs, Dan Raghinaru, Richard M. Bergenstal, Andrew Ahmann, Anne L. Peters, Bruce W. Bode, Grazia Aleppo, Irl B. Hirsch, Lora Kleis, H. Peter Chase, Stephanie N. DuBose, Kellee M. Miller, Roy W. Beck, Saleh Adi	245
17	Corneal Graft Rejection 10 Years After Penetrating Keratoplasty in the Cornea Donor Study 2014 ·Cornea ·Steven P. Dunn, Robin L. Gal, Craig Kollman, Dan Raghinaru, Mariya Dontchev, (unknown), Edward J. Holland, Jonathan H. Lass, Kenneth R. Kenyon, Mark J. Mannis, Shahzad I. Mian, Christopher J. Rapuano, Walter J. Stark, Roy W. Beck	47
18	Frequency of Morning Ketosis After Overnight Insulin Suspension Using an Automated Nocturnal Predictive Low Glucose Suspend System 2014 ·Diabetes Care ·Roy W. Beck, Dan Raghinaru, R. Paul Wadwa, H. Peter Chase, David M. Maahs, Bruce A. Buckingham, (unknown)	32
19	Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia 2012 ·Journal of Vascular Surgery ·Salvatore T. Scali, Catherine K. Chang, Dan Raghinaru, Michael J. Daniels, Adam W. Beck, Robert J. Feezor, Scott A. Berceli, Thomas S. Huber	21
20	Late Outcomes of a Single-Center Experience of 400 Consecutive Thoracic Endovascular Aortic Repairs 2011 ·Circulation ·W. Anthony Lee, Michael J. Daniels, Thomas M. Beaver, C.T. Klodell, Dan Raghinaru, Philip J. Hess	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact